Live Chat ×
Skip to main content

Ethics and medical marijuana: What you need to know

Speaker:
Patricia Carothers, BSN, RN, MS, CCM

Description and CE information:
Medical marijuana is now legal in 33 states and the District of Columbia, but there is little research on its effective use. As new acronyms like CBD and THC enter the health care vocabulary, case managers must adapt in an ethics and evidence-based manner. This webinar will offer an overview of the components of cannabis and the evidence for its use in palliative care, as well as ethical implications for case managers.
Learning Outcomes:

  • Identify key legal, regulatory and coverage issues that impact patient access to using medical marijuana in its various formulations;
  • Describe ethically appropriate responses to common scenarios where patients and/or families have expressed interest in using medical marijuana as part of their treatment plan; and
  • Develop an approach to anticipate and address common barriers to treatment, including incorporating advocacy on behalf of clients and their treatment preferences in interaction with providers, payers and caregivers.
Credit Information:

The Commission for Case Manager Certification (CCMC) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board certified case managers. The course is approved for 1 Ethics CE contact hour(s). Activity code and Approval number will be awarded on your certificate of completion.

Disclosures:All planners and speakers have disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Commercial Support or Non-Commercial Sponsorship:There is no commercial support for this activity. The planners and faculty have no relevant relationships to disclose.

Expiration date: 9/25/2022